X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (761) 761
female (482) 482
index medicus (479) 479
male (477) 477
middle aged (407) 407
aged (376) 376
adult (287) 287
gastroenterology & hepatology (239) 239
cancer (237) 237
oncology (237) 237
medicine & public health (180) 180
aged, 80 and over (174) 174
surgery (168) 168
liver (167) 167
cholangiocarcinoma (152) 152
analysis (125) 125
hepatology (122) 122
gastroenterology (120) 120
retrospective studies (120) 120
prognosis (112) 112
tumors (110) 110
carcinoma (109) 109
pathology (102) 102
animals (98) 98
biliary tract (96) 96
bile duct neoplasms - pathology (94) 94
bile (93) 93
treatment outcome (91) 91
diagnosis (88) 88
risk factors (88) 88
abdominal surgery (85) 85
biliary tract neoplasms - pathology (85) 85
survival (84) 84
chemotherapy (82) 82
immunohistochemistry (82) 82
medicine (82) 82
immunology (78) 78
research article (77) 77
health aspects (76) 76
patients (73) 73
gallbladder (71) 71
expression (69) 69
cholangiocarcinoma - pathology (68) 68
research (68) 68
liver diseases (65) 65
gallbladder cancer (64) 64
surgical oncology (63) 63
pancreatic cancer (61) 61
diagnosis, differential (60) 60
liver cancer (59) 59
biliary tract cancer (58) 58
biliary-tract (58) 58
colorectal surgery (58) 58
mortality (58) 58
hepatocellular-carcinoma (57) 57
liver neoplasms - pathology (57) 57
biliary tract neoplasms - immunology (56) 56
neoplasm staging (56) 56
pancreas (55) 55
adenocarcinoma (54) 54
science (53) 53
bile ducts, intrahepatic (52) 52
biliary tract neoplasms - drug therapy (52) 52
biliary-tract cancer (52) 52
care and treatment (52) 52
intrahepatic cholangiocarcinoma (52) 52
gemcitabine (51) 51
multidisciplinary sciences (50) 50
abridged index medicus (49) 49
gastroenterology and hepatology (49) 49
medical research (49) 49
bile duct neoplasms - surgery (48) 48
biliary tract neoplasms - diagnosis (48) 48
epidemiology (48) 48
general surgery (48) 48
mice (48) 48
cardiac surgery (47) 47
metastasis (47) 47
thoracic surgery (47) 47
vascular surgery (47) 47
biliary tract neoplasms - mortality (46) 46
adolescent (45) 45
disease (45) 45
primary sclerosing cholangitis (45) 45
management (44) 44
medical prognosis (44) 44
internal medicine (43) 43
primary biliary-cirrhosis (43) 43
survival analysis (43) 43
biochemistry, general (42) 42
pancreatitis (42) 42
cell biology (41) 41
diseases (41) 41
gallbladder neoplasms - pathology (41) 41
hepatocellular carcinoma (41) 41
medical colleges (41) 41
pancreatic neoplasms - pathology (41) 41
sensitivity and specificity (41) 41
survival rate (41) 41
hepatectomy (40) 40
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (30) 30
Scarborough Hospital - General (2) 2
Credit Valley Hospital - Reference (1) 1
Gerstein Science - Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Reference (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (827) 827
Japanese (15) 15
German (6) 6
French (3) 3
Italian (2) 2
Polish (2) 2
Russian (2) 2
Chinese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Letters, ISSN 0304-3835, 2017, Volume 402, pp. 9 - 15
Abstract The human intestinal microbiome encompasses at least 100 trillion microorganisms that can influence host immunity and disease conditions, including... 
Hematology, Oncology and Palliative Medicine | Pancreatic adenocarcinoma | Bacteria | Hepatocellular carcinoma | Gut–liver axis | Cholangiocarcinoma | BILIARY-TRACT CANCER | INTESTINAL MICROBIOTA | FATTY LIVER-DISEASE | LONG-TERM SURVIVAL | RANDOMIZED CONTROLLED-TRIAL | GUT MICROBIOTA | FUSOBACTERIUM-NUCLEATUM | HEPATOCELLULAR-CARCINOMA | ONCOLOGY | POSTOPERATIVE INFECTIOUS COMPLICATIONS | HELICOBACTER-HEPATICUS | Gut-liver axis | Immunotherapy - methods | Humans | Antineoplastic Agents - therapeutic use | Liver Neoplasms - therapy | Dysbiosis | Gastrointestinal Tract - immunology | Gastrointestinal Tract - surgery | Biliary Tract Neoplasms - therapy | Liver Neoplasms - pathology | Biliary Tract Neoplasms - pathology | Biliary Tract Neoplasms - microbiology | Pancreatic Neoplasms - pathology | Gastrointestinal Tract - microbiology | Gastrointestinal Tract - drug effects | Liver Neoplasms - immunology | Biliary Tract Neoplasms - immunology | Liver Neoplasms - microbiology | Host-Pathogen Interactions | Cell Transformation, Neoplastic - immunology | Animals | Digestive System Surgical Procedures | Pancreatic Neoplasms - immunology | Pancreatic Neoplasms - microbiology | Gastrointestinal Microbiome - immunology | Cell Transformation, Neoplastic - pathology | Pancreatic Neoplasms - therapy | Microbiota (Symbiotic organisms) | Liver | College graduates | Development and progression | Metastasis | Liver cancer | Chemotherapy | Metabolites | Cell death | Analysis | Pancreatic cancer | Immunotherapy | Cancer | Animal models | DNA damage | Clinical trials | Immunity | Metastases | Hepatitis | Microorganisms | CTLA-4 protein | Cell growth | Pathways | E coli | Intestine | Rodents | Surgery | Damage | Digestive tract | Deoxyribonucleic acid--DNA | Obesity | Liver diseases | Complications | Invasiveness | Inflammation | Patients | Survival | Cancer surgery | Studies | Probiotics | Diet | Antibiotics | Medical prognosis | Liver cirrhosis | Tumors
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 07/2014, Volume 124, Issue 7, pp. 3241 - 3251
Journal Article
Journal of Gastrointestinal Surgery, ISSN 1091-255X, 9/2013, Volume 17, Issue 9, pp. 1609 - 1617
Journal Article
Journal Article
Journal Article
Anticancer Research, ISSN 0250-7005, 10/2017, Volume 37, Issue 10, pp. 5541 - 5552
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2017, Volume 86, pp. 158 - 165
Although biliary tract cancers (BTCs) are known to have an inflammatory component, a detailed characterisation of immune-related transcripts has never been... 
CTLA4 | Adjuvant | CD80 | Cholangiocarcinoma | Treg | CELLS | INTRAHEPATIC CHOLANGIOCARCINOMA | PHASE-II | INTERLEUKIN-6 | TUMORS | GEMCITABINE | CHEMOTHERAPY | BREAST-CANCER | ONCOLOGY | HUMAN-MALIGNANT CHOLANGIOCYTES | EXPRESSION | Forkhead Transcription Factors - immunology | Multivariate Analysis | Tumor Escape | B7-1 Antigen - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Transcriptome | Tumor Microenvironment | Male | Biliary Tract Surgical Procedures | T-Lymphocytes, Regulatory - immunology | Time Factors | Adult | Female | Retrospective Studies | Biliary Tract Neoplasms - genetics | Biliary Tract Neoplasms - pathology | B7-1 Antigen - immunology | Kaplan-Meier Estimate | Proportional Hazards Models | CTLA-4 Antigen - genetics | Gene Expression Profiling - methods | Treatment Outcome | Biliary Tract Neoplasms - immunology | CTLA-4 Antigen - immunology | Forkhead Transcription Factors - genetics | Biliary Tract Neoplasms - surgery | Disease-Free Survival | Italy | Aged | Biomarkers, Tumor - genetics | Biomarkers, Tumor - immunology | Lymphocytes, Tumor-Infiltrating - immunology | Lymphocytes | Oncology, Experimental | Analysis | Immunotherapy | Adjuvant treatment | Research | Cancer | TT, tumour tissue | IL-6, interleukin 6 | AT, adjacent tissue | CTLA4, cytotoxic T-lymphocyte antigen-4 | APC, antigen-presenting cell | BTC, biliary tract cancer | ECC, extrahepatic CCA | POLR2A, RNA polymerase II subunit A | FFPE, formalin fixed paraffin embedded | CD80, cluster of differentiation 80 | Treg, T regulatory cell | R1, positive resection margins | TGFB1, transforming growth factor beta | GBC, gallbladder cancer | ICC, intrahepatic CCA | R0, clear resection margins | RFS, relapse-free survival | IPA, ingenuity pathway analysis | CCA, cholangiocarcinoma | IP, immune profile | PBK, PDZ binding kinase
Journal Article
Hepatology, ISSN 0270-9139, 11/2016, Volume 64, Issue 5, pp. 1785 - 1791
Biliary tract cancers (BTC) comprise a group of uncommon malignancies in which the standard therapies are minimally effective and evolve slowly. Like the... 
SURVIVAL | TRIAL | CELLS | CHOLANGIOCARCINOMA | HEPATOCELLULAR-CARCINOMA | HLA CLASS-I | IMMUNOTHERAPY | PEPTIDE VACCINATION | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | CANCER | Immunotherapy - methods | Biliary Tract Neoplasms - immunology | Humans | Translational Medical Research | Biliary Tract Neoplasms - therapy | Biliary tract | Etiology | Immune system
Journal Article
Journal Article
Journal Article